Samsung Biologics to Acquire PolyPeptide via CHF 1.46 Billion Public Tender Offer

Source Summary

Homburger has advised PolyPeptide Group AG. Lenz & Staehelin has advised Draupnir Holding B.V., PolyPeptide’s largest shareholder. Samsung Biologics has launched an all-cash public tender offer [...]